EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

LOGO

 

NEWS RELEASE

 

Contact:   Karey L. Witty
    Chief Financial Officer
    (314) 725-4477
    Lisa M. Wilson
    Senior Vice President, Investor Relations
    (212) 759-3929

 

CENTENE CORPORATION REPORTS TWENTY-FOURTH CONSECUTIVE

QUARTER OF INCREASED PROFITABILITY

 

ST. LOUIS, MISSOURI (July 25, 2005) — Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended June 30, 2005.

 

Second Quarter Highlights

 

    Revenues of $349.6 million, a 49.7% increase over the second quarter of 2004.

 

    Consistent healthcare cost trends generating an 81.0% health benefits ratio.

 

    Earnings from operations of $22.3 million, a 40.1% increase over the second quarter of 2004.

 

    Earnings per diluted share of $0.34, a 36.0% increase from the second quarter of 2004.

 

    Membership growth of 54.8% over the second quarter of 2004.

 

    Days in claims payable of 49.5, net of 1.2 days for payments on claims in litigation.

 

    Closed acquisition of Medicaid-related assets of SummaCare, Inc., based in Akron, Ohio.

 

    Elected Tommy G. Thompson, former U.S. Health and Human Services (HHS) Secretary and former Governor of Wisconsin, to Board of Directors.

 

Subsequent Events

 

    Announced tentative award of contracts by State of Texas for existing and new service areas.

 

    Awarded Medicaid contracts by State of Georgia for Atlanta and Central regions, two of the largest service areas, with approximately 500,000 and 150,000 eligibles, respectively.

 

Michael F. Neidorff, Centene’s chairman and chief executive officer, said, “The second quarter of 2005 marked our twenty-fourth consecutive quarter of increased profitability and was fully in-line with our expectations. We remain pleased with the progress in our states, particularly with


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 2

 

the solid growth in the Kansas and Wisconsin markets. The roll-out of SSI membership in Wisconsin is on track, and we continue to see organic growth in that market. Membership trends have been strong in Kansas following the removal of the membership cap. As predicted and guided, our year-to-date organic membership growth was light. We want to remind you that we elected not to participate in the Southern Indiana expansion, which we viewed as a high cost market.

 

“Our 81.0% health benefits ratio remained at the low end of our target range with the SSI HBR at 85.2% for the current quarter. Our recently announced acquisition of AirLogix enhances our demonstrated ability to manage healthcare costs for our growing SSI opportunity.

 

“There were a number of events marking the success of the quarter. Notably, we received notice of the tentative contract awards by the State of Texas for the STAR and CHIP members in our existing service areas of Austin, El Paso, Lubbock and San Antonio, and new service area expansion awards to serve both STAR and CHIP members in the Corpus Christi market. We expect these contracts to be finalized on or before August 17, 2005 and become effective July 1, 2006. Also, on May 1, 2005, we closed the acquisition of the Medicaid-related assets of SummaCare, Inc., a wholly owned subsidiary of Summa Health System, based in Akron, Ohio. We look forward to capitalizing on additional opportunities to grow in this State.

 

“As we progress in 2005 and beyond, we are confident that our consistent strategic objectives will continue to produce predictable financial results and identify cost-savings in Medicaid managed care,” concluded Neidorff.


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 3

 

The following table depicts membership in Centene’s managed care organizations by state at June 30, 2005 and 2004:

 

     2005

   2004

Indiana

   152,800    132,900

Kansas

   103,000    —  

Missouri

   39,900    —  

New Jersey

   52,900    54,000

Ohio

   59,600    23,800

Texas

   243,800    155,300

Wisconsin

   173,400    167,300
    
  

TOTAL

   825,400    533,300
    
  

 

The following table depicts membership in Centene’s managed care organizations by member category at June 30, 2005 and 2004:

 

     2005

    2004

 

Medicaid

   637,300     460,300  

SCHIP

   176,200     63,200  

SSI

   11,900 (a)   9,800 (b)
    

 

TOTAL

   825,400     533,300  
    

 


(a) 5,500 at-risk; 6,400 ASO
(b) 4,400 at-risk; 5,400 ASO

 

Statement of Earnings Highlights

 

    For the second quarter of 2005, revenues increased 49.7% to $349.6 million from $233.6 million in the second quarter of 2004.

 

    The health benefits ratio (HBR), which reflects medical services costs as a percent of premium revenues, remained consistent at 81.0% period-over-period. The Company’s SSI HBR was within the guided range of 84.0% to 86.0%, demonstrating Centene’s ability to manage this population. While growing, Centene’s small SSI member base can experience a volatile HBR, period-over-period.


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 4

 

    General and administrative (G&A) expenses as a percent of revenues were 12.7% in the second quarter of 2005 compared to 12.1% in the second quarter of 2004. As previously guided, the results for the second quarter of 2005 included approximately $1.3 million in implementation costs relative to Centene’s Arizona behavioral health contract award, effective July 1, 2005.

 

    Earnings from operations increased 40.1% to $22.3 million in the second quarter of 2005 from $15.9 million in the second quarter of 2004.

 

    Net earnings improved to $15.2 million, or $0.34 per diluted share, in the second quarter of 2005 compared to $10.8 million, or $0.25 per diluted share, for the second quarter of 2004.

 

    For the six months ended June 30, 2005, revenues increased 48.5% to $682.0 million from $459.1 million for the same period in the prior year. The HBR remained consistent at 81.0% period-over-period. General and administrative expenses as a percent of revenues increased slightly to 12.7% in the first half of 2005 compared to 12.4% in the first half of 2004. Earnings from operations increased 42.5% to $43.6 million in the first half of 2005 from $30.6 million in the first half of 2004. Net earnings improved to $29.7 million, or $0.66 per diluted share, in the first half of 2005.

 

Balance Sheet and Cash Flow Highlights

 

At June 30, 2005, the Company had cash and investments of $287.9 million, including $27.4 million held by its unregulated entities and $260.5 million held by its regulated entities. Medical claims liabilities totaled $153.6 million, representing 49.5 days in claims payable. This included a 1.2 day decrease related to payments on disputed claims in litigation.


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 5

 

A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter-end is presented below:

 

Days in claims payable, March 31, 2005    59.7  
Decrease in claims inventory    (5.8 )
Payment of annual physician performance bonuses    (3.0 )
Payment on disputed claims in litigation    (1.2 )
Decrease in pharmacy payable    (0.2 )
    

Days in claims payable, June 30, 2005    49.5  
    

 

Cash flows used in operating activities were $7.0 million for the six months ended June 30, 2005. As expected, this primarily reflected the State of Wisconsin’s holding our June capitation payment of approximately $29 million until after June 30, 2005, the State’s fiscal year-end. This amount was received in July. In addition, cash flow for the quarter was affected by the anticipated decline in medical claims liabilities. The following table depicts the significant uses of cash flows from operations year-to-date:

 

(in millions)     
Increase in Wisconsin premium and related receivables    $ 28.6
Reduction in claims inventory      18.1
Payment of annual physician performance bonuses      9.3
Income tax payments      7.9
Payment on disputed claims in litigation      3.6

 

New Opportunity

 

In July 2005, the Company received notification that the State of Georgia had awarded to the Company’s subsidiary, Peach State Health Plan, contracts to serve a portion of the Medicaid recipients in two of the State’s largest regions, Atlanta and Central. These two service areas represent a combined 650,000 eligible members and present a significant organic growth opportunity for 2006 and beyond. The Company has structured the organization with the critical management team in place and believes it will be able to serve this new marketplace successfully and to work with the State on a smooth transition.


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 6

 

Outlook

 

Karey L. Witty, Centene’s chief financial officer, stated, “We are revising our 2005 earnings guidance to include an estimated $7.5 to $10.0 million in implementation costs related to the Georgia contract award. We will continue to provide quarterly updates as these expenditures occur. Additionally, we are including our recently announced acquisition of AirLogix. We continue to maintain organic membership growth of 10% to 12% for 2005. This revised guidance excludes the potential impact of any other acquisitions we may undertake during the remainder of 2005 as well as expenses related to stock option grants under SFAS 123R, which is required to be adopted on January 1, 2006. Consistent with prior practices, we will provide a preliminary outlook for 2006 in conjunction with our third quarter 2005 earnings announcement.”

 

The table below depicts the Company’s revised guidance for the balance of 2005:

 

     Q3

    Q4

 
     Low

    High

    Low

    High

 

Revenue (in millions)

   $ 398.0     $ 403.0     $ 429.0     $ 452.0  

Earnings per share without Georgia

   $ 0.36     $ 0.37     $ 0.37     $ 0.41  

Georgia implementation costs

     (0.04 )     (0.03 )     (0.10 )     (0.07 )
    


 


 


 


Adjusted earnings per share

   $ 0.32     $ 0.34     $ 0.27     $ 0.34  
    


 


 


 


 

Conference Call

 

As previously announced, the Company will host a conference call tomorrow, July 26, 2005, at 8:30 a.m. (Eastern Time) to review the financial results for the second quarter ended June 30, 2005, and to discuss its business outlook. Michael F. Neidorff and Karey L. Witty will host the conference call. Investors are invited to participate in the conference call by dialing 800-273-1254 in the U.S. and Canada, 706-679-8592 from abroad, or via a live Internet broadcast on the Company’s website at www.centene.com, under the Investor Relations section. A replay will be available for on demand listening shortly after the completion of the call until 11:59 PM Eastern Time on August 19, 2005 at the aforementioned URL, or by dialing 800-642-1687 in the U.S. and Canada, or 706-645-9291 from abroad, and entering access code 7237632.


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 7

 

About Centene Corporation

 

Centene Corporation provides multi-line managed care programs and related services to individuals receiving benefits under Medicaid, including Supplemental Security Income (SSI), and the State Children’s Health Insurance Program (SCHIP). The Company operates health plans in Indiana, Kansas, Missouri, New Jersey, Ohio, Texas and Wisconsin. In addition, the Company contracts with other organizations to provide specialty services including behavioral health, disease management, nurse triage and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.

 

The information provided in the second, third and fourth paragraphs following the bullet listing under “Second Quarter Highlights,” the paragraph under “New Opportunity” and the paragraph under “Outlook” above contain forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company’s estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene’s Medicaid managed care contracts by state governments would also negatively affect Centene.

 

[Tables Follow]


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 8

 

CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

    

June 30,

2005


   

December 31,

2004


 
     (Unaudited)        
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 65,598     $ 84,105  

Premium and related receivables, net of allowances of $437 and $462, respectively

     69,839       31,475  

Short-term investments, at fair value (amortized cost $65,453 and $94,442, respectively)

     65,337       94,283  

Other current assets

     16,482       14,429  
    


 


Total current assets

     217,256       224,292  

Long-term investments, at fair value (amortized cost $135,626 and $117,177, respectively)

     134,621       116,787  

Restricted deposits, at fair value (amortized cost $22,507 and $22,295, respectively)

     22,323       22,187  

Property, software and equipment

     48,479       43,248  

Goodwill

     130,262       101,631  

Other intangible assets

     15,188       14,439  

Other assets

     6,317       5,350  
    


 


Total assets

   $ 574,446     $ 527,934  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Medical claims liabilities

   $ 153,593     $ 165,980  

Accounts payable and accrued expenses

     31,045       31,737  

Unearned revenue

     9,657       3,956  

Current portion of long-term debt and notes payable

     486       486  
    


 


Total current liabilities

     194,781       202,159  

Long-term debt

     52,731       46,973  

Other liabilities

     8,215       7,490  
    


 


Total liabilities

     255,727       256,622  

Stockholders’ equity:

                

Common stock, $.001 par value; authorized 100,000,000 shares; issued and outstanding 42,481,098 and 41,316,122 shares, respectively

     42       41  

Additional paid-in capital

     183,539       165,391  

Accumulated other comprehensive income:

                

Unrealized loss on investments, net of tax

     (809 )     (407 )

Retained earnings

     135,947       106,287  
    


 


Total stockholders’ equity

     318,719       271,312  
    


 


Total liabilities and stockholders’ equity

   $ 574,446     $ 527,934  
    


 



Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 9

 

CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands, except share data)

 

    

Three Months Ended

June 30,


   

Six Months Ended

June 30,


 
     2005

    2004

    2005

    2004

 
     (Unaudited)     (Unaudited)  

Revenues:

                                

Premiums

   $ 348,416     $ 231,330     $ 679,360     $ 454,020  

Services

     1,212       2,278       2,644       5,113  
    


 


 


 


Total revenues

     349,628       233,608       682,004       459,133  
    


 


 


 


Expenses:

                                

Medical costs

     282,215       187,298       549,971       367,746  

Cost of services

     728       2,022       1,571       4,038  

General and administrative expenses

     44,365       28,351       86,824       56,728  
    


 


 


 


Total operating expenses

     327,308       217,671       638,366       428,512  
    


 


 


 


Earnings from operations

     22,320       15,937       43,638       30,621  

Other income (expense):

                                

Investment and other income

     2,523       1,336       4,643       2,846  

Interest expense

     (634 )     (101 )     (1,196 )     (191 )
    


 


 


 


Earnings before income taxes

     24,209       17,172       47,085       33,276  

Income tax expense

     8,960       6,359       17,425       12,325  
    


 


 


 


Net earnings

   $ 15,249     $ 10,813     $ 29,660     $ 20,951  
    


 


 


 


Earnings per share:

                                

Basic earnings per common share

   $ 0.36     $ 0.27     $ 0.71     $ 0.52  

Diluted earnings per common share

   $ 0.34     $ 0.25     $ 0.66     $ 0.48  

Weighted average number of shares outstanding:

                                

Basic

     42,203,946       40,721,466       41,884,044       40,552,742  

Diluted

     45,087,772       43,374,376       44,984,818       43,221,426  


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 10

 

CENTENE CORPORATION AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

    

Six Months Ended

June 30,


 
     2005

    2004

 
     (Unaudited)  

Cash flows from operating activities:

                

Net earnings

   $ 29,660     $ 20,951  

Adjustments to reconcile net earnings to net cash provided by operating activities —

                

Depreciation and amortization

     5,901       4,701  

Deferred income taxes

     1,191       (914 )

Tax benefits related to stock options

     3,782       1,507  

Stock compensation expense

     2,304       32  

Loss (gain) on sale of investments

     39       (103 )

Changes in assets and liabilities —

                

Premium and related receivables

     (38,364 )     (989 )

Other current assets

     (2,224 )     (1,051 )

Other assets

     (946 )     (330 )

Medical claims liabilities

     (12,387 )     3,536  

Unearned revenue

     5,701       (23 )

Accounts payable and accrued expenses

     (2,716 )     3,747  

Other operating activities

     1,034       (950 )
    


 


Net cash (used in) provided by operating activities

     (7,025 )     30,114  
    


 


Cash flows from investing activities:

                

Purchase of property, software and equipment

     (8,768 )     (5,082 )

Purchase of investments

     (74,928 )     (154,342 )

Sales and maturities of investments

     84,984       151,077  

Acquisitions, net of cash acquired

     (21,342 )     (7,005 )
    


 


Net cash used in investing activities

     (20,054 )     (15,352 )
    


 


Cash flows from financing activities:

                

Reduction of long-term debt and notes payable

     (4,242 )     (435 )

Proceeds from borrowings

     10,000       —    

Proceeds from stock options and employee stock purchase plan

     2,864       1,805  

Other financing

     (50 )     —    
    


 


Net cash provided by financing activities

     8,572       1,370  
    


 


Net (decrease) increase in cash and cash equivalents

     (18,507 )     16,132  
    


 


Cash and cash equivalents, beginning of period

     84,105       64,346  
    


 


Cash and cash equivalents, end of period

   $ 65,598     $ 80,478  
    


 


Interest paid

   $ 1,209     $ 181  

Income taxes paid

   $ 12,904     $ 11,034  

Supplemental schedule of non-cash investing and financing activities:

                

Common stock issued for acquisitions

   $ 8,995     $ —    


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 11

 

CENTENE CORPORATION AND SUBSIDIARIES

 

SUPPLEMENTAL FINANCIAL DATA

 

    

Q2

2005


  

Q1

2005


  

Q4

2004


  

Q3

2004


MEMBERSHIP

                           

Indiana

     152,800      149,900      150,600      150,000

Kansas

     103,000      94,900      94,200      —  

Missouri

     39,900      41,300      41,200      —  

New Jersey

     52,900      52,700      52,800      53,200

Ohio

     59,600      23,900      23,800      23,500

Texas

     243,800      243,700      244,300      250,200

Wisconsin

     173,400      170,900      165,800      164,700
    

  

  

  

TOTAL

     825,400      777,300      772,700      641,600
    

  

  

  

Medicaid

     637,300      588,100      580,200      479,500

SCHIP

     176,200      178,500      182,100      152,100

SSI

     11,900      10,700      10,400      10,000
    

  

  

  

TOTAL

     825,400      777,300      772,700      641,600
    

  

  

  

REVENUE PER MEMBER

   $ 143.41    $ 142.15    $ 139.38    $ 144.70

CLAIMS

                           

Period-end inventory

     195,500      227,700      150,300      141,200

Average inventory

     170,300      191,900      128,300      96,800

Period-end inventory per member

     0.24      0.29      0.19      0.22

DAYS IN CLAIMS PAYABLE (a)

     49.5      59.7      66.5      57.3

(a) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.

 

CASH AND INVESTMENTS (in millions)

                                

Regulated

   $ 260.5     $ 295.0     $ 271.4     $ 200.3  

Unregulated

     27.4       42.1       46.0       123.3  
    


 


 


 


TOTAL

   $ 287.9     $ 337.1     $ 317.4     $ 323.6  
    


 


 


 


ANNUALIZED RETURN ON EQUITY (b)

     20.0 %     20.5 %     18.2 %     18.2 %

(b) Annualized Return on Equity is calculated as follows: (net income for quarter x 4) divided by ((beginning of period equity + end of period equity) divided by 2).


Centene Corporation Reports Twenty-Fourth Consecutive Quarter of Increased Profitability July 25, 2005 / Page 12

 

HEALTH BENEFITS RATIO BY CATEGORY:

 

    

Three Months Ended

June 30,


   

Six Months Ended

June 30,


 
     2005

    2004

    2005

    2004

 

Medicaid and SCHIP

   80.9 %   80.5 %   80.8 %   80.5 %

SSI

   85.2     97.8     89.3     98.5  

Total

   81.0     81.0     81.0     81.0  

 

GENERAL AND ADMINISTRATIVE EXPENSE RATIO BY BUSINESS SEGMENT:

 

    

Three Months Ended

June 30,


   

Six Months Ended

June 30,


 
     2005

    2004

    2005

    2004

 

Medicaid Managed Care

   10.5 %   10.2 %   10.6 %   10.3 %

Specialty Services

   58.8     46.4     54.6     49.7  

Total

   12.7     12.1     12.7     12.4  

 

MEDICAL CLAIMS LIABILITIES

(In thousands)

 

Four rolling quarters of the changes in medical claims liabilities are summarized as follows:

 

Balance, June 30, 2004

   $ 110,105  

Acquisitions

     24,909  

Incurred related to:

        

Current period

     997,061  

Prior period

     (14,360 )
    


Total incurred

     982,701  
    


Paid related to:

        

Current period

     869,428  

Prior period

     94,694  
    


Total paid

     964,122  
    


Balance, June 30, 2005

   $ 153,593  
    


 

Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability. Any reduction in the “Incurred related to: Prior period” claims may be offset as Centene actuarially determines “Incurred related to: Current period.” As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.